The Blazer Bridge Fund encourages discovery among the UAB community by providing financial support to innovative ideas and inventions.

The 9th Annual Birmingham Ride to Eradicate Parkinson’s, part of the Team Rowland Road Series, will be Saturday, Oct. 4 at Oak Mountain State Park.

National Advanced Practice Provider (APP) Week, held annually in late September, recognizes the essential role of APPs in healthcare.

Seven faculty members in the UAB Department of Neurology have been promoted, and two have received awards of tenure, effective Oct. 1, 2025,

A UAB neurologist shares how symptoms of various movement disorders can be treated with deep brain stimulation therapy.

The UAB ALS Multidisciplinary Clinic has been designated a Certified Treatment Center of Excellence (CTCE) by the ALS Association, a recognition that underscores its commitment to providing the highest standard of care for patients and families living with ALS.

When most people think about their health, they focus on the body: the heart, the lungs, the muscles. But what about the brain?

UAB Hospital has once again been recognized among the nation’s top hospitals for neurology and neurosurgery, according to the 2025-2026 U.S. News & World Report Best Hospitals rankings.

The UAB Department of Neurology welcomed Felicia Hataway, M.D., to the faculty as assistant professor in the Division of Cerebrovascular Disease in July 2025.

Victor Sung, M.D., professor in the UAB Department of Neurology, has been named the next director of the Division of Movement Disorders. Anthony Nicholas, M.D., Ph.D., who left UAB in May 2025, previously served as director of the Division since 2017.

In August 2025, UAB will celebrate the opening of a new Epilepsy Monitoring Unit (EMU), a facility that will more than double patient capacity, increase patient access to services, and enhance research and training opportunities.

Alzheimer’s disease doesn’t impact all communities equally, and understanding why may be one of the most urgent questions in public health today. Chad Murchison, Ph.D., assistant professor in the UAB Departments of Neurology and Biostatistics, is helping unravel that mystery not through a microscope but through data.

A recent study authored by UAB researchers in the departments of Neurology, Medicine, and Epidemiology analyzed a decade of data to reveal that lack of access to stroke-related clinical trials may limit access to innovative treatments in geographic regions with high stroke burdens.

Jeremy Herskowitz, Ph.D., Patsy W. and Charles A.

July 22 marks the 12th annual World Brain Day, a global campaign led by the World Federation of Neurology (WFN) to promote brain health across all stages of life. This year’s theme, “Brain Health for All Ages,” emphasizes the importance of neurological care from preconception through late adulthood.

The published study found a correlation between first-time transient ischemic attack and future cognitive decline. Rates of decline between TIA and stroke participants were the same.

The UAB Heersink School of Medicine is among eight academic medical centers worldwide selected to train a new movement disorder clinician-researcher through the distinguished Edmond J. Safra Fellowship in Movement Disorders for the class of 2028.

Giovanna Pilonieta, Ph.D., DDS, MPH, assistant professor in the UAB Department of Neurology, was recently named one of two 2025 recipients of the McKnight Clinical Translational Research Scholarship in Cognitive Aging and Age-Related Memory Loss. Pilonieta was awarded along with Deborah Rose, M.D., of the National Institutes of Health.

Knowing the symptoms and acting quickly in a stroke emergency can help to minimize long-term effects.

Burt Nabors, M.D., professor in the University of Alabama at Birmingham Department of Neurology and director of the Division of Neuro-oncology, has been selected as a recipient of the 2025 Excellence in Engagement Award from the National Comprehensive Cancer Network (NCCN).

The UAB Brain Aging and Memory Clinic opened in spring 2024, marking a new era of care in the field of Alzheimer’s disease and other memory-related disorders for Alabama and the region. One initiative the new space has helped support is clinical trials, bolstering UAB’s status as a performance site for the clinical trials of the most recent generation of anti-Alzheimer therapies. 

A powerful philanthropic partnership is transforming research and treatment of intellectual and developmental disabilities. Before there were MRI machines or CT scans—never mind the possibility of using AI to unlock the mysteries of the human brain—there was Civitan International.

David S. Geldmacher, M.D., FANA, FACP, professor, Warren Family Endowed Chair, Vice Chair for Clinical Affairs, and Director of the Division of Cognitive and Behavioral Neurology in the UAB Department of Neurology, has been appointed to the rank of University Professor.

Anthony P. Nicholas, M.D., Ph.D., recently left UAB after spending 29 years as a faculty member in the Department of Neurology.

This spring, the University of Alabama System Board of Trustees awarded the rank of Distinguished Professor to five and the rank of University Professor to four faculty members.

Chronic stress can increase inflammation in the brain, which can impact sleep, cognition and memory and potentially increase one’s risk for neurodegenerative diseases.

The Killion family of Birmingham has given a $10 million gift to UAB to create the Wayne Killion Endowment for the Center for Neurodegeneration and Experimental Therapeutics and to rename the center the Killion Center for Neurodegeneration and Experimental Therapeutics.

Getting a good start is critical, as is exercise, building community and more.

Via virtual submissions, UAB Medicine now offers remote second opinions from specialized care experts on diagnoses and treatment options.

Ronald Lazar, Ph.D., director of UAB’s Evelyn F. McKnight Brain Institute, explains effective interventions, the importance of choice and why you should start where you are.